| NCT00001060 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
|
PHASE1 |
View
|
| NCT00001059 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
|
PHASE2 |
View
|
| NCT00001058 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS
|
PHASE2 |
View
|
| NCT00001057 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients
|
PHASE2 |
View
|
| NCT00001056 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose
|
PHASE1 |
View
|
| NCT00001050 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
TERMINATED |
Study of Women Who Have AIDS
|
|
View
|
| NCT00001035 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections
|
PHASE1 |
View
|
| NCT00001034 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV
|
PHASE2 |
View
|
| NCT00001033 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
The Treatment of Tuberculosis in HIV-Infected Patients
|
PHASE3 |
View
|
| NCT00001032 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT
|
PHASE2 |
View
|
| NCT00001020 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)
|
PHASE1 |
View
|
| NCT00001018 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea
|
PHASE1 |
View
|
| NCT00001016 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies
|
PHASE3 |
View
|
| NCT00001006 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC)
|
PHASE1 |
View
|
| NCT00001005 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes
|
PHASE1 |
View
|
| NCT00001004 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex
|
PHASE2 |
View
|
| NCT00001003 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia
|
NA |
View
|
| NCT00001002 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time
|
PHASE1 |
View
|
| NCT00001000 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection
|
NA |
View
|
| NCT00000995 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection
|
NA |
View
|
| NCT00000994 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
|
PHASE3 |
View
|
| NCT00000993 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus
|
NA |
View
|
| NCT00000992 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS
|
PHASE1 |
View
|
| NCT00000969 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) Therapy
|
NA |
View
|
| NCT00000968 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)
|
PHASE1 |
View
|
| NCT00000967 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children
|
PHASE1 |
View
|
| NCT00000966 |
Positive Gene Therapy |
Pfizer |
COMPLETED |
A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS
|
PHASE1 |
View
|
| NCT00000961 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
TERMINATED |
The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected Infants
|
PHASE2 |
View
|
| NCT00000960 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants
|
PHASE3 |
View
|
| NCT00000959 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection
|
NA |
View
|
| NCT00000958 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)
|
PHASE1 |
View
|
| NCT00000957 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules
|
PHASE1 |
View
|
| NCT00000956 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
|
PHASE1 |
View
|
| NCT00000951 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush
|
PHASE4 |
View
|
| NCT00000950 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
|
NA |
View
|
| NCT00000935 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens
|
PHASE3 |
View
|
| NCT00000933 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048
|
|
View
|
| NCT00000932 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of the Long-Term Outcomes of HIV-Positive Patients
|
|
View
|
| NCT00000920 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
|
PHASE1 |
View
|
| NCT00000918 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure
|
PHASE2 |
View
|
| NCT00000912 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients
|
PHASE2 |
View
|
| NCT00000905 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy
|
|
View
|
| NCT00000904 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults
|
PHASE1 |
View
|
| NCT00000903 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen
|
PHASE3 |
View
|
| NCT00000902 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment
|
PHASE1 |
View
|
| NCT00000895 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection
|
NA |
View
|
| NCT00000894 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis
|
PHASE4 |
View
|
| NCT00000893 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children
|
PHASE1 |
View
|
| NCT00000892 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir
|
NA |
View
|
| NCT00000869 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies
|
PHASE3 |
View
|
| NCT00000868 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers
|
PHASE1 |
View
|
| NCT00000867 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)
|
PHASE2 |
View
|
| NCT00000866 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.
|
NA |
View
|
| NCT00000861 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected Patients
|
NA |
View
|
| NCT00000860 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients
|
|
View
|
| NCT00000859 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3
|
NA |
View
|
| NCT00000858 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other Infections
|
|
View
|
| NCT00000857 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3
|
PHASE1 |
View
|
| NCT00000856 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
WITHDRAWN |
A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.
|
PHASE1 |
View
|
| NCT00000851 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children
|
PHASE2 |
View
|
| NCT00000850 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy
|
PHASE2 |
View
|
| NCT00000835 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
WITHDRAWN |
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine
|
|
View
|
| NCT00000834 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Study of Methotrexate for HIV Infection
|
PHASE1 |
View
|
| NCT00000833 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.
|
PHASE1 |
View
|
| NCT00000832 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers
|
PHASE1 |
View
|
| NCT00000827 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children
|
PHASE1 |
View
|
| NCT00000820 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy
|
PHASE2 |
View
|
| NCT00000818 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Evaluation of the Changes in HIV-1 Burden in Peripheral Blood and Lymphoid Tissue Following Zidovudine ( AZT ) Treatment in HIV-1-Infected Patients With CD4+ Cells Between 100 and 500 Cells/mm3.
|
PHASE1 |
View
|
| NCT00000806 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Randomized Dose/Formulation Comparison Study of SC-52151
|
PHASE1 |
View
|
| NCT00000805 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
|
PHASE1 |
View
|
| NCT00000804 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
WITHDRAWN |
A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)
|
NA |
View
|
| NCT00000803 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy
|
PHASE2 |
View
|
| NCT00000802 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides
|
PHASE3 |
View
|
| NCT00000795 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects
|
PHASE1 |
View
|
| NCT00000794 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
|
PHASE2 |
View
|
| NCT00000793 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection
|
PHASE2 |
View
|
| NCT00000792 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects
|
PHASE1 |
View
|
| NCT00000769 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma
|
PHASE1 |
View
|
| NCT00000768 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients
|
PHASE1 |
View
|
| NCT00000767 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV-1 IIIB Env/Gag/Pol Vaccine (TBC-3B)
|
PHASE1 |
View
|
| NCT00000766 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
CMV Retinitis Retreatment Trial
|
PHASE2 |
View
|
| NCT00000761 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-Infected Children
|
PHASE1 |
View
|
| NCT00000760 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patients With HIV Infection
|
PHASE1 |
View
|
| NCT00000759 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials
|
|
View
|
| NCT00000758 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women
|
PHASE3 |
View
|
| NCT00000757 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
|
PHASE1 |
View
|
| NCT00000756 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3
|
PHASE1 |
View
|
| NCT00000751 |
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
COMPLETED |
A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)
|
PHASE3 |
View
|
| NCT00000750 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection
|
PHASE3 |
View
|
| NCT00000735 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC
|
PHASE1 |
View
|
| NCT00000734 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Evaluation of the Interaction Between High Dose Sulfamethoxazole/Trimethoprim and Zidovudine
|
NA |
View
|
| NCT00000733 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients
|
PHASE1 |
View
|
| NCT00000732 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Evaluation of the Interaction Between Low Dose Sulfamethoxazole-Trimethoprim and Zidovudine
|
NA |
View
|
| NCT00000720 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine
|
PHASE3 |
View
|
| NCT00000718 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC
|
NA |
View
|
| NCT00000705 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia
|
PHASE1 |
View
|
| NCT00000704 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC.
|
PHASE1 |
View
|
| NCT00000703 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members
|
NA |
View
|
| NCT00000702 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection
|
PHASE3 |
View
|
| NCT00000695 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma
|
PHASE1 |
View
|
| NCT00000694 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma
|
PHASE1 |
View
|
| NCT00000693 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS
|
NA |
View
|
| NCT00000692 |
|
G D Searle |
COMPLETED |
Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex
|
PHASE1 |
View
|
| NCT00000669 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection
|
PHASE1 |
View
|
| NCT00000668 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir
|
PHASE1 |
View
|
| NCT00000667 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells
|
PHASE1 |
View
|
| NCT00000666 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection
|
NA |
View
|
| NCT00000661 |
Positive Gene Therapy |
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
The Pharmacokinetics of Zidovudine and Oxazepam Alone and in Combination in the HIV-Infected Patient
|
PHASE1 |
View
|
| NCT00000660 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
|
PHASE1 |
View
|
| NCT00000659 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
TERMINATED |
A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)
|
PHASE2 |
View
|
| NCT00000658 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma
|
PHASE3 |
View
|
| NCT00000657 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex
|
PHASE2 |
View
|
| NCT00000656 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease
|
PHASE1 |
View
|
| NCT00000651 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy
|
PHASE3 |
View
|
| NCT00000650 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients
|
NA |
View
|
| NCT00000635 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical Trifluridine
|
NA |
View
|
| NCT00000634 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children
|
NA |
View
|
| NCT00000633 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive Individuals
|
PHASE1 |
View
|
| NCT00000632 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59
|
PHASE1 |
View
|
| NCT00000627 |
|
National Institute of Allergy and Infectious Diseases (NIAID) |
COMPLETED |
Pilot Study to Determine the Feasibility of Fluconazole for Induction Treatment and Suppression of Relapse of Histoplasmosis in Patients With the Acquired Immunodeficiency Syndrome
|
NA |
View
|
| NCT00000620 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
|
PHASE3 |
View
|
| NCT00000606 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
National Emphysema Treatment Trial (NETT)
|
PHASE3 |
View
|
| NCT00000605 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Estrogen and Graft Atherosclerosis Research Trial (EAGER)
|
PHASE3 |
View
|
| NCT00000604 |
|
Baystate Medical Center |
COMPLETED |
Influence of CPB Temperature on CABG Morbidity
|
PHASE2 |
View
|
| NCT00000603 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Cord Blood Stem Cell Transplantation Study (COBLT)
|
PHASE2 |
View
|
| NCT00000602 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)
|
PHASE2 |
View
|
| NCT00000595 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
|
PHASE2 |
View
|
| NCT00000594 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
NHLBI Type II Coronary Intervention Study
|
PHASE3 |
View
|
| NCT00000593 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Viral Activation Transfusion Study (VATS)
|
NA |
View
|
| NCT00000592 |
|
Augusta University |
COMPLETED |
Stroke Prevention in Sickle Cell Anemia (STOP 1)
|
PHASE3 |
View
|
| NCT00000569 |
|
University of Minnesota |
COMPLETED |
Lung Health Study II
|
PHASE3 |
View
|
| NCT00000568 |
Positive Gene Therapy |
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Lung Health Study (LHS) I and III
|
PHASE3 |
View
|
| NCT00000567 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
High Frequency Ventilation in Premature Infants (HIFI)
|
PHASE3 |
View
|
| NCT00000566 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)
|
PHASE3 |
View
|
| NCT00000561 |
Positive Gene Therapy |
Mt. Sinai Medical Center, Miami |
COMPLETED |
Mode Selection Trial in Sinus Node Dysfunction (MOST)
|
PHASE3 |
View
|
| NCT00000560 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Beta-Blocker Evaluation in Survival Trial (BEST)
|
PHASE3 |
View
|
| NCT00000559 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
|
PHASE3 |
View
|
| NCT00000558 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
|
PHASE3 |
View
|
| NCT00000557 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients
|
PHASE3 |
View
|
| NCT00000556 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
|
PHASE3 |
View
|
| NCT00000551 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Activity Counseling Trial (ACT)
|
PHASE3 |
View
|
| NCT00000550 |
|
Carelon Research |
COMPLETED |
Rapid Early Action for Coronary Treatment (REACT)
|
PHASE3 |
View
|
| NCT00000535 |
Positive Gene Therapy |
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Trial of Nonpharmacologic Interventions in Elderly (TONE)
|
PHASE3 |
View
|
| NCT00000534 |
|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
COMPLETED |
Calcium for Pre-Eclampsia Prevention (CPEP)
|
PHASE3 |
View
|
| NCT00000533 |
|
McGill University |
COMPLETED |
Montreal Heart Attack Readjustment Trial (M-HART)
|
PHASE3 |
View
|
| NCT00000532 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Women's Healthy Lifestyle Project: Cardiovascular Risk Factors and Menopause
|
PHASE3 |
View
|
| NCT00000520 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Prevention of Coronary Aneurysms in Kawasaki Syndrome
|
PHASE2 |
View
|
| NCT00000518 |
|
University of Utah |
COMPLETED |
Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
|
PHASE3 |
View
|
| NCT00000512 |
|
University of Washington |
COMPLETED |
Familial Atherosclerosis Treatment Study
|
PHASE3 |
View
|
| NCT00000505 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Thrombolysis in Myocardial Infarction (TIMI)
|
PHASE3 |
View
|
| NCT00000504 |
Positive Gene Therapy |
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Cardiac Arrhythmia Pilot Study (CAPS)
|
PHASE2 |
View
|
| NCT00000503 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
|
PHASE3 |
View
|
| NCT00000502 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Evaluation of SC-V Versus Conventional CPR
|
PHASE3 |
View
|
| NCT00000495 |
|
Northwestern University |
COMPLETED |
Prevention of Hypertension: A Randomized Trial
|
PHASE3 |
View
|
| NCT00000494 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Management of Patent Ductus in Premature Infants
|
PHASE3 |
View
|
| NCT00000493 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Multicenter Investigation of Limitation of Infarct Size (MILIS)
|
PHASE3 |
View
|
| NCT00000492 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Beta-Blocker Heart Attack Trial (BHAT)
|
PHASE3 |
View
|
| NCT00000469 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Asymptomatic Carotid Artery Plaque Study (ACAPS)
|
PHASE2 |
View
|
| NCT00000468 |
|
University of Washington |
COMPLETED |
Myocardial Infarction Triage and Intervention Project (MITI)
|
PHASE3 |
View
|
| NCT00000467 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Child and Adolescent Trial for Cardiovascular Health (CATCH)
|
PHASE3 |
View
|
| NCT00000466 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Postmenopausal Estrogen/Progestin Interventions (PEPI)
|
PHASE3 |
View
|
| NCT00000461 |
|
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Harvard Atherosclerosis Reversibility Project (HARP)
|
PHASE2 |
View
|
| NCT00000460 |
|
University of Alabama at Birmingham |
WITHDRAWN |
Training Levels Comparison Trial
|
|
View
|
| NCT00000459 |
Positive Gene Therapy |
National Heart, Lung, and Blood Institute (NHLBI) |
COMPLETED |
Dietary Intervention Study in Children (DISC)
|
PHASE3 |
View
|
| NCT00000458 |
Positive Gene Therapy |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
COMPLETED |
Sertraline and Cognitive Therapy in Depressed Alcoholics
|
PHASE2 |
View
|
| NCT00000457 |
|
Mayo Clinic |
COMPLETED |
Pharmacologic Relapse Prevention for Alcoholic Smokers
|
PHASE2 |
View
|
| NCT00000456 |
|
Medical University of South Carolina |
COMPLETED |
Behavioral Therapy Plus Naltrexone for Alcoholism
|
PHASE4 |
View
|
| NCT00000451 |
|
Yale University |
COMPLETED |
Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)
|
PHASE2 |
View
|
| NCT00000450 |
|
The Scripps Research Institute |
COMPLETED |
Naltrexone Maintenance Treatment of Alcoholism
|
PHASE4 |
View
|
| NCT00000435 |
|
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
COMPLETED |
dnaJ Peptide for Relieving Rheumatoid Arthritis
|
PHASE2 |
View
|
| NCT00000434 |
|
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
COMPLETED |
Impact of Exercise on Older Persons With Osteoarthritis
|
PHASE2 |
View
|
| NCT00000433 |
|
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
COMPLETED |
Blocking Tumor Necrosis Factor in Ankylosing Spondylitis
|
PHASE2 |
View
|
| NCT00000432 |
|
Brigham and Women's Hospital |
COMPLETED |
Lyme Disease Prevention Program
|
PHASE3 |
View
|
| NCT00000427 |
|
Massachusetts General Hospital |
COMPLETED |
Effects of Parathyroid Hormone in Men With Osteoporosis
|
PHASE3 |
View
|
| NCT00000420 |
|
NYU Langone Health |
COMPLETED |
Safety of Estrogens in Lupus: Birth Control Pills
|
PHASE3 |
View
|
| NCT00000418 |
|
Indiana University |
COMPLETED |
Psychosocial Treatment for Acute Low Back Pain
|
PHASE2 |
View
|
| NCT00000406 |
Positive Gene Therapy |
Indiana University |
COMPLETED |
Effects of Strength Training on Knee Osteoarthritis
|
PHASE2 |
View
|
| NCT00000405 |
|
Oregon State University |
COMPLETED |
Effects of Jumping on Growing Bones
|
PHASE2 |
View
|
| NCT00000404 |
|
Indiana University |
COMPLETED |
Effects of Comprehensive Care for Knee OA
|
PHASE2 |
View
|
| NCT00000403 |
|
Indiana University |
COMPLETED |
Doxycycline and OA Progression
|
PHASE3 |
View
|
| NCT00000402 |
|
Ohio State University |
COMPLETED |
Calcium and Bone Mass in Young Females
|
PHASE2 |
View
|
| NCT00000395 |
Positive Gene Therapy |
University of Alabama at Birmingham |
COMPLETED |
Antifolate Effectiveness in Arthritis
|
PHASE2 |
View
|
| NCT00000394 |
|
George Washington University |
COMPLETED |
Acupuncture for Carpal Tunnel Syndrome
|
PHASE2 |
View
|
| NCT00000393 |
|
National Institute of Mental Health (NIMH) |
COMPLETED |
A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS).
|
PHASE1 |
View
|
| NCT00000392 |
|
National Institute of Mental Health (NIMH) |
COMPLETED |
Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.
|
PHASE2 |
View
|
| NCT00000369 |
Positive Gene Therapy |
University of Pittsburgh |
COMPLETED |
Maintenance Therapies in Bipolar Disorders
|
PHASE3 |
View
|
| NCT00000368 |
|
New York State Psychiatric Institute |
COMPLETED |
Treatment of Panic Disorder: Long Term Strategies
|
PHASE3 |
View
|
| NCT00000367 |
|
Weill Medical College of Cornell University |
COMPLETED |
Prevention of Suicide in the Elderly
|
NA |
View
|
| NCT00000361 |
|
National Institute on Deafness and Other Communication Disorders (NIDCD) |
TERMINATED |
Autoimmunity in Inner Ear Disease
|
PHASE3 |
View
|
| NCT00000359 |
|
Baylor College of Medicine |
COMPLETED |
Treatments for Benign Paroxysmal Positional Vertigo (BPPV)
|
PHASE2 |
View
|
| NCT00000358 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
|
PHASE1 |
View
|
| NCT00000357 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Buprenorphine Maintenance for Opiate Dependence - 6
|
PHASE2 |
View
|
| NCT00000356 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
|
PHASE2 |
View
|
| NCT00000351 |
|
National Institute on Drug Abuse (NIDA) |
UNKNOWN |
Cognitive Correlates of Substance Abuse, Part 2 - 16
|
|
View
|
| NCT00000350 |
|
National Institute on Drug Abuse (NIDA) |
UNKNOWN |
Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
|
PHASE1 |
View
|
| NCT00000335 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Activity Monitoring Assessment of Opiate Withdrawal - 4
|
PHASE2 |
View
|
| NCT00000334 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Comparison of Buprenorphine and Methadone - 3
|
PHASE2 |
View
|
| NCT00000333 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
Evaluation of Benztropine for Cocaine Craving - 2
|
PHASE2 |
View
|
| NCT00000332 |
|
National Institute on Drug Abuse (NIDA) |
COMPLETED |
High Dose Nimodipine Treatment Adjunct - 1
|
PHASE2 |
View
|
| NCT00000328 |
|
University of Colorado, Denver |
WITHDRAWN |
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
|
PHASE2 |
View
|
